Background & Aims: A new tool, the Geriatric Nutritional Risk Index (GNRI), was recently proposed to predict short-term complications in elderly medical patients but no information is available when long-term follow-up periods are considered.
Methods: A 3-year follow-up study in 245 institutionalised elderly (51 M:194 F; 83.7+/-8.6 years). Nutritional risk was graded by GNRI (severe, <82; moderate, 82 to <92; mild, 92-98; no risk, >98). Main outcome was overall-cause death.
Results: After the follow-up 99 (26 M:73 F) events occurred. Nutritional risk prevalence was 5.7%, 24.1%, 34.7% and 35.5% and mortality rates were 71.4%, 48.6% 33.7% and 34.3% with the GNRI<82, 82 to <92, 92-98, and >98, respectively. Kaplan-Meier curves were significantly associated to GNRI (p=0.0068). GNRI<82 was consistently related to death (odds ratio, OR=5.29, [95%CI: 1.43-19.57], p=0.0127) when compared to GNRI>98. Similar results were confirmed by Cox regression (hazard ratio, HR=2.76 [95%CI: 1.89-4.03], p=0.0072). Finally, when "severe" and "moderate" risk were analysed as a single class (GNRI<92) outcome associations were: OR=2.17, [95%CI: 1.10-4.28] (p=0.0245); HR=1.76 [95%CI: 1.34-2.23] (p=0.0315). Survival analysis showed higher mortality rates by GNRI<92 (p=0.0188).
Conclusions: Present data support the use of the GNRI in the evaluation of long-term nutrition-related risk of death. We suggest a GNRI<92 as clinical trigger for nutritional support in institutionalised elderly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clnu.2008.07.005 | DOI Listing |
J Med Microbiol
January 2025
Departamento de Bioqumica e Imunologia, Instituto de Cincias Biolgicas, Universidade Federal de Minas Gerais.
Apolipoprotein E (ApoE), especially the ApoE4 isotype, is suggested to influence the severity of respiratory viral infections; however, this association is still unclear. The presence of allele ε4 impacts the development of flu-like syndromes. This study aimed to evaluate the impact of the Apo E4 isoform on the severity and duration of flu-like syndromes, including the coronavirus disease COVID-19.
View Article and Find Full Text PDFJAMA
January 2025
Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Sleep Breath
January 2025
Department of Otolaryngology, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, China.
Background: This study aimed to investigate the association between Obstructive Sleep Apnea (OSA) and Tinnitus using NHANES data from 2005 to 2020.
Methods: This study analyzed data from NHANES (National Health and Nutrition Examination Surveys) conducted between 2005 and 2020, and included 4871 participants aged 16 or older. OSA was assessed using the Multivariate Apnea Prediction Index and the variables from the National Health and Nutrition Examination Survey.
Alzheimers Dement
January 2025
Department of Neurology, Inha University College of Medicine, Incheon, Republic of Korea.
Introduction: We investigated the efficacy of a multidomain intervention (MI) via face-to-face and video communication platforms using a tablet personal computer application in patients with mild cognitive impairment (MCI).
Methods: Three hundred participants with MCI and ≥ 1 modifiable dementia risk factor, aged 60-85 years, were randomly assigned to either the MI group, who underwent a 24-week intervention, or the control group, who received usual care.
Results: The overall adherence rate to MI was 84.
Aim: This study aims to investigate the clinical utility of the derived neutrophil-to-lymphocyte ratio (dNLR) and the Geriatric Nutritional Risk Index (GNRI) in predicting treatment outcomes for patients with unresectable hepatocellular carcinoma (HCC) undergoing combination therapy with atezolizumab and bevacizumab (Atez/Bev).
Methods: A retrospective analysis was conducted on 310 patients. The dNLR, NLR, and GNRI were calculated, and their impact on progression-free survival (PFS) and overall survival (OS) was assessed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!